2017
DOI: 10.1016/j.mehy.2017.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Anastasis and the ER stress response: Solving the paradox of the unfolded protein response in cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 34 publications
0
9
0
Order By: Relevance
“…Signatures of surviving cells from previous non-apocalyptic chemotherapeutic treatments did not match that of PAMEs: 0/9 and 2/11 genes described in Tang et al (2012;2017), 3/37 in Berthenet et al (2020), and <1% (4/759 late UP genes and 19/2,210 UP genes by at least 2-fold) described in Sun et al (2017) were also UP in PAMEs. Indeed, only 3/31 genes (SNAIL1, VIM, and IL32) mentioned in this subsection were similarly regulated in a previous study (Sun et al, 2017).…”
Section: Enhanced Expression Of Secreted Stemness and Metastatic Repr...mentioning
confidence: 88%
See 1 more Smart Citation
“…Signatures of surviving cells from previous non-apocalyptic chemotherapeutic treatments did not match that of PAMEs: 0/9 and 2/11 genes described in Tang et al (2012;2017), 3/37 in Berthenet et al (2020), and <1% (4/759 late UP genes and 19/2,210 UP genes by at least 2-fold) described in Sun et al (2017) were also UP in PAMEs. Indeed, only 3/31 genes (SNAIL1, VIM, and IL32) mentioned in this subsection were similarly regulated in a previous study (Sun et al, 2017).…”
Section: Enhanced Expression Of Secreted Stemness and Metastatic Repr...mentioning
confidence: 88%
“…(1) Cells surviving an impending or near-death experience display high ER stress (Figure 7E) enhanced by the engaged processes (e.g., apoptosis, ferroptosis, and EMT; Feng et al, 2014;Zeindl-Eberhart et al, 2014;Dixon et al, 2014;Urra et al, 2016;Manalo, 2017). Such impending death may also be triggered by oncogenic, hypoxia, or drug-treatment events through ER stress involving PERK-CHOP (Tabas and Ron, 2011;Oakes, 2020;Hetz et al, 2020) (Figure 7E).…”
Section: Discussionmentioning
confidence: 99%
“…Despite the development of novel therapeutic approaches against human cardiovascular and cancer diseases, effective interventions will require determining the mechanisms that regulate cell fate decisions during cellular stress conditions. The problem, however, is that the molecular crosstalk between these pathways remains largely unexplained and limited to cancer cell models [ 51 , 52 , 53 , 54 , 55 , 56 , 57 ]. Notably, despite the fact that hypoxia has been reported to activate UPR signaling in order to modulate cancer progression [ 5 , 54 , 58 , 59 ], the cancer cell-based models often rely on unique genetic and epigenetic modifications that allow these cells to bypass cell fate decisions during both hypoxia and the UPR.…”
Section: Discussionmentioning
confidence: 99%
“…UPR regulates immune function both in induction of pathogen response and inhibition of autoimmunity [164]. Another context in which UPR is of particular interest is tumor development and tumor microenvironment [21,23,29,31,32,39,48,[165][166][167][168]. The role of UPR has been investigated in many types of cancer, suggesting that targeting UPR will be a viable strategy regardless of cancer origin and mutations.…”
Section: Discussionmentioning
confidence: 99%